Risk Factors Associated with Acquisition of ESBL Escherichia Coli Infection, Detection and Treatment, a Case Report

Authors

  • Dr. Gadangi Indira

  • Dr. Gadangi Indira

Keywords:

ESBL, escherichia coli, CLSI, MIC method, PICC line cephalosporinsand ertapenem

Abstract

ESBL group of organisms are beta lactamase enzyme producing organisms capable of breaking the beta lactam ring in antibiotics hence are resistant to usually cephalosporins and few other antibiotics. In these E.coli is the most common bacteria that lives in gut harmlessly but causes Urinary tract infection and in severe cases blood poisoning, septicemia or bacteremia leading to serious sepsis. When not treated it leads to inflammation of body parts, blood clots, blocking oxygen supply and ultimately causing death. In present study report a 51 years old Indian tourist patient was admitted in a Wake Med Health hospital at USA, with symptoms of UTI.In hospital she was diagnosed with ESBL E.coliUTI infection with>100,000 colonies /ml and blood culture showed positive result. In this case the Sepsiswas resulted as secondary infection. She even suffered with chronic anemia. The previous medical history of subject showed several risk factors for acquisition of infection. These include elder age, female gender,chronic anemia, recent hospitalization, surgical procedure (due to hysterectomy), intravenous catheterization, intensive careand prolonged usage of high potency antibiotics.All these factors are established as predictive and prognostic risk factors for acquisition of infection and also results in colonization of organism.

How to Cite

Risk Factors Associated with Acquisition of ESBL Escherichia Coli Infection, Detection and Treatment, a Case Report. (2014). Global Journal of Medical Research, 14(C6), 23-26. https://medicalresearchjournal.org/index.php/GJMR/article/view/758

References

S Anunnatsriri, P Towiwat, P Chaimanee (2012) Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital, Thailand. Southeast Asian J. 43(5), 1169-1177.

Ronen Ben‐ami, Jesús Rodríguez‐baño, Hande Arslan, Johann Pitout, Claudine Quentin, Esther Calbo, Özlem Azap, Corinne Arpin, Alvaro Pascual, David Livermore, Javier Garau, Yehuda Carmeli (2009) A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase-Producing Enterobacteriaceae in Nonhospitalized Patients. 49(5), 682-690.

M Cormican, D Morris, G Corbett-Feeney, J Flynn (1998) Extendedspectrum-beta-lactamase production and fluoroquinolone resistance in pathogens associated with communityacquired urinary tract infection. 32, 317-319.

E Lautenbach, J Patel, W Bilker, P Edelstein, N Fishman (2001) Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Infection and Impact of Resistance on Outcomes. 32(8), 1162-1171.

J Ena, F Arjona, C Martínez-Peinado (2006) Epidemiology of urinary tract infections caused by extended-spectrumbeta-lactamase producing Escherichia coli. 68(6), 1169-1174.

Cheol-In Kang, Jae-Hoon Song, Doo Chung, Kyong Peck, Kwan Ko, Joon-Sup Yeom, Hyun Ki, Jun Son, Seung Lee, Yeon-Sook Kim, Sook-In Jung, Shin-Woo Kim, Hyun-Ha Chang, Seong Ryu, Ki Kwon, Hyuck Lee, Chisook Moon, Sang Shin (2010) Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli. 36(3), 284-287.

F-X Lescure, M Eveillard, Y Douadi, F Eb (2001) Community-acquired multiresistant bacteria: an emerging problem?. 49(2), 149-151.

Kenneth Meyer, Carl Urban, Janet Eagan, Barbara Berger, James Rahal (1993) Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins. 119(5), 353-358.

W Brown (1997) National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteria. 32(3), 385-390.

S Nijssen, A Florijn, M Bonten, F Schmitz, J Verhoef, A Fluit (2004) Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. 24(6), 585-591.

M Ortega, F Marco, A Soriano (2009) Analysis of 4,758 Escherichia colibacteraemia episodes: predictive factors for isolation of an antibioticresistant strain and their impact on the outcome. 63, 15.

Narinhiransuthikula Pairojsaonuama, Kumthornmalathumc Chusana-Suankratayb (2008) Somwang Danchaivijitrda491 Risk factors for nosocomial infections caused by extended-spectrum βlactamase producing Escherichia coli or Klebsiellapneumoniae in Thailand. 2(6), 485.

J Rodriguez-Bano (2008) Risk Factors for Community-Acquired Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli. 169(8), 811.

Jesús Rodríguez-Baño, Maria Navarro, Luisa Romero, Luis Martínez-Martínez, Miguel Muniain, Evelio Perea, Ramón Pérez-Cano, Alvaro Pascual (2004) Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients. 42(3), 1089-1094.

Didier Tandé, Nelle Jallot, Flabou Bougoudogo, Tracey Montagnon, Stéphanie Gouriou, Jacques Sizun (2009) Extended-Spectrum β-Lactamase-ProducingEnterobacteriaceaein a Malian Orphanage. 15(3), 472-474.

Risk Factors Associated with Acquisition of ESBL Escherichia Coli Infection, Detection and Treatment, a Case Report

Published

2014-11-05

How to Cite

Risk Factors Associated with Acquisition of ESBL Escherichia Coli Infection, Detection and Treatment, a Case Report. (2014). Global Journal of Medical Research, 14(C6), 23-26. https://medicalresearchjournal.org/index.php/GJMR/article/view/758